DAF deficiency is associated with Inab phenotype (absence of all blood group antigens of the Cromer complex). Clinically,
PNH (paroxysmal nocturnal hemoglobinuria) usually affects young adults and has a variable course of intravascular haemolysis, pancytopenia, and recurrent (usually venous) thromboses. It often arises in patients with aplastic anaemia, and may transform into acute myeloblastic leukaemia. Complications include iron deficiency (from chronic haemoglobinuria), progressive renal impairment (from haemoglobinuria), and the Budd Chiari syndrome (hepatic vein thrombosis).
Diagnosis
Diagnostic recommendations
Additional Information
- Paroxysmal nocturnal hemoglobinuria, ORPHANET
- Difetti del complemento, Informagene
- Paroxysmal nocturnal hemoglobinuria, eMedicine
- Paroxysmal Nocturnal Hemoglobinuria, Tripod website
- Paroxysmal Nocturnal Hemoglobinuria, Heidelberg University
- Complement deficiency, eMedicine
- Complement deficiency, eMedicine
- Paroxysmal nocturnal hemoglobinuria, The Doctor's Doctor
Diagnostic laboratories
Clinical:
Genetic:
Therapeutic options
- Treatment is primarily symptomatic (transfusion, erythropoietin, glucocorticoids, anticoagulation) or includes, in severe cases, bone marrow transplantation. Techniques for the suppression of complement activation with monoclonal antibodies are currently under development.
- Complement deficiency, eMedicine
- Complement deficiency, eMedicine
- Paroxysmal nocturnal hemoglobinuria, eMedicine